Eric L Matteson Selected Research

Rheumatoid Vasculitis

1/2015	Rheumatoid vasculitis: an update.
1/2009	Vasculitis in rheumatoid arthritis.
1/2005	The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis.
5/2004	Management of extra-articular disease manifestations in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric L Matteson Research Topics

Disease

62	Rheumatoid Arthritis 01/2022 - 01/2002
20	Infections 01/2022 - 01/2002
12	Giant Cell Arteritis (Horton Disease) 01/2022 - 10/2006
11	Vasculitis (Vasculitides) 01/2022 - 05/2004
11	Inflammation (Inflammations) 01/2022 - 06/2004
10	Neoplasms (Cancer) 12/2017 - 05/2006
9	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 12/2005
8	Lung Diseases (Lung Disease) 01/2022 - 05/2004
8	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022 - 08/2010
7	Arthritis (Polyarthritis) 01/2021 - 02/2006
7	Sarcoidosis (Schaumann Disease) 09/2019 - 06/2004
6	Idiopathic Pulmonary Fibrosis 01/2022 - 12/2018
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2011
5	Fibrosis (Cirrhosis) 12/2021 - 01/2008
5	Pain (Aches) 04/2017 - 12/2004
5	Heart Failure 01/2016 - 09/2012
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 11/2011
4	Rheumatic Diseases (Rheumatism) 11/2019 - 03/2011
4	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2019 - 12/2003
4	Hypertension (High Blood Pressure) 01/2018 - 02/2016
4	Rheumatoid Vasculitis 01/2015 - 05/2004
4	Necrosis 10/2014 - 07/2009
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2008
3	Systemic Scleroderma (Systemic Sclerosis) 12/2021 - 01/2008
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 03/2012
3	Fibromyalgia (Fibrositis) 01/2020 - 05/2016
3	Microscopic Polyangiitis 01/2019 - 03/2014
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 10/2012
3	Joint Diseases (Joint Disease) 01/2019 - 02/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2014
3	Venous Thromboembolism 01/2018 - 03/2014
3	Osteoarthritis 01/2018 - 02/2006
3	Takayasu Arteritis (Arteritis, Takayasu's) 05/2016 - 07/2012
3	Tuberculosis (Tuberculoses) 01/2016 - 02/2013
3	Rheumatoid Nodule 03/2014 - 01/2002
3	Psoriatic Arthritis 01/2014 - 07/2012
3	Ankylosing Spondylitis 01/2014 - 07/2012
3	Shoulder Pain 04/2012 - 03/2011
2	Osteoporosis 01/2022 - 01/2018
2	Aneurysm (Aneurysms) 01/2020 - 10/2009
2	Connective Tissue Diseases (Connective Tissue Disease) 09/2019 - 05/2014
2	Diabetes Mellitus 01/2018 - 09/2012
2	Gout 01/2018 - 06/2015
2	Cataract (Cataracts) 01/2018 - 01/2018
2	Neurosarcoidosis 11/2017 - 01/2017
2	Hypercalcemia (Milk Alkali Syndrome) 01/2017 - 06/2004
2	Dyslipidemias (Dyslipidemia) 02/2016 - 08/2014

Drug/Important Bio-Agent (IBA)

21	GlucocorticoidsIBA 01/2022 - 10/2006
13	Biological ProductsIBA 01/2021 - 05/2012
12	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 05/2004
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 05/2004
11	golimumab FDA Link 01/2015 - 04/2008
8	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 12/2003
8	Rheumatoid FactorIBA 01/2020 - 01/2002
7	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2016 - 12/2004
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2009
6	LipidsIBA 11/2017 - 10/2012
6	AntibodiesIBA 01/2017 - 05/2006
6	C-Reactive ProteinIBA 01/2017 - 08/2009
6	Tumor Necrosis Factor InhibitorsIBA 01/2015 - 05/2004
5	CytokinesIBA 01/2020 - 01/2008
5	Monoclonal AntibodiesIBA 01/2019 - 12/2004
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 05/2004
5	Prednisone (Sone)FDA LinkGeneric 10/2016 - 03/2003
4	Antirheumatic Agents (DMARD)IBA 01/2022 - 05/2012
4	CholesterolIBA 01/2021 - 10/2012
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2006
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018 - 01/2017
4	AutoantibodiesIBA 12/2017 - 02/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2008
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2012
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021 - 05/2014
3	tofacitinibIBA 01/2020 - 01/2016
3	Prednisolone (Predate)FDA LinkGeneric 10/2019 - 11/2012
3	Opioid Analgesics (Opioids)IBA 11/2017 - 05/2016
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2017 - 01/2009
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017 - 06/2004
3	Peptides (Polypeptides)IBA 01/2017 - 01/2009
3	Dihydrotachysterol (AT 10)IBA 01/2017 - 01/2015
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2016 - 05/2015
3	HLA-DRB1 Chains (HLA DRB1)IBA 09/2006 - 01/2005
3	Infliximab (Remicade)FDA Link 05/2006 - 08/2002
2	nintedanibIBA 01/2022 - 01/2021
2	Carbon MonoxideIBA 01/2022 - 12/2021
2	baricitinibIBA 01/2022 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2020
2	Antinuclear AntibodiesIBA 01/2020 - 08/2007
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 03/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 10/2011
2	Uric Acid (Urate)IBA 01/2017 - 06/2015
2	Pharmaceutical PreparationsIBA 10/2016 - 11/2009
2	VaccinesIBA 01/2016 - 01/2016

Therapy/Procedure

40	Therapeutics 11/2019 - 03/2003
4	Orthopedic Procedures 10/2018 - 01/2002
4	Biological Therapy 10/2017 - 05/2014
3	Arthroplasty 07/2014 - 01/2002
3	Replacement Arthroplasty 07/2014 - 01/2002
2	Length of Stay 01/2018 - 01/2017